Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure

Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure

Dysphagia is prevalent in patients with cervical dystonia (CD) and is a potential adverse event in patients treated with botulinum neurotoxin (BoNT) for CD. Real-world studies may provide a better understanding of the incidence and potential risk factors of dysphagia after BoNT administration. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard L. Barbano, Bahman Jabbari, Marjan Sadeghi, Ahunna Ukah, Emma Yue, Kimberly Becker Ifantides, Nuo-Yu Huang, David Swope
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Toxins
Subjects:
cervical dystonia
botulinum neurotoxin
dysphagia
incidence
comorbidity
real-world evidence
Online Access:https://www.mdpi.com/2072-6651/17/3/148
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2072-6651/17/3/148

Similar Items